Brooke Robert T. 4/A
4/A · Vitality Biopharma, Inc. · Filed Apr 25, 2019
Insider Transaction Report
Form 4/AAmended
Brooke Robert T.
VP of Business Devevlopment
Transactions
- Award
Common Stock
2016-07-15+510,585→ 965,585 total
Footnotes (1)
- [F1]The Form 4 filed on August 17, 2016 listed 510,585 RSU's as vesting on March 1, 2017 and March 1, 2018. This was reported incorrectly. The shares awarded were not RSU's, they were restricted common stock. The vesting of the restricted common stock was initially granted with the following vesting schedule: 255,293 of the shares shall vest on March 1, 2017 and 255,292 of the shares shall vest on March 1, 2018. That restricted common stock award was amended and restated with the following vesting schedule: 255,293 of the shares shall vest on January 1, 2018 and 255,292 of the shares shall vest on March 1, 2018. Further, the restricted common stock award was amended and restated a second time with the following vesting schedule: 510,585 of the shares shall vest on January 1, 2019.